NUMIF (Numinus Wellness) Accounts Payable & Accrued Expense: $2.31 Mil (As of May. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Numinus Wellness Accounts Payable & Accrued Expense?

Numinus Wellness NUMIF +0.15% Accounts Payable & Accrued Expense is $2.31 Mil as of May. 2025.

Numinus Wellness's quarterly accounts payable & accrued expense declined from Nov. 2024 ($2.16 Mil) to Feb. 2025 ($1.94 Mil) but then increased from Feb. 2025 ($1.94 Mil) to May. 2025 ($2.31 Mil).

Numinus Wellness's annual accounts payable & accrued expense declined from Aug. 2022 ($2.25 Mil) to Aug. 2023 ($2.14 Mil) and declined from Aug. 2023 ($2.14 Mil) to Aug. 2024 ($1.48 Mil).

Numinus Wellness Accounts Payable & Accrued Expense Historical Data

* Premium members only.

The historical data trend for Numinus Wellness's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Numinus Wellness Accounts Payable & Accrued Expense Chart

Numinus Wellness Annual Data
Trend Aug19 Aug20 Aug21 Aug22 Aug23 Aug24
Accounts Payable & Accrued Expense
Get a 7-Day Free Trial 1.44 1.15 2.25 2.14 1.48

Numinus Wellness Quarterly Data
Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25
Accounts Payable & Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.60 1.48 2.16 1.94 2.31

Numinus Wellness Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

What does a Accounts Payable & Accrued Expense of $2.31 Mil mean?
Numinus Wellness (NUMIF) has a Accounts Payable & Accrued Expense of $2.31 Mil as of May. 2025. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Numinus Wellness and its competitors.
Is Numinus Wellness' Accounts Payable & Accrued Expense too high?
Numinus Wellness' current Accounts Payable & Accrued Expense is $2.31 Mil.
How does Numinus Wellness' Accounts Payable & Accrued Expense compare to HLYK and SYRA?
Numinus Wellness' Accounts Payable & Accrued Expense of $2.31 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable & Accrued Expense for a Healthcare Providers & Services company?
A good Accounts Payable & Accrued Expense depends on the Healthcare Providers & Services industry context. However, Accounts Payable & Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable & Accrued Expense mean?
A high Accounts Payable & Accrued Expense can signal that a stock is expensive relative to its fundamentals. Accounts payable and accrued expenses are amounts a company expects to pay to suppliers and others. View historical data on Numinus Wellness and its competitors. Numinus Wellness's current Accounts Payable & Accrued Expense is $2.31 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Numinus Wellness stock overvalued right now?
Numinus Wellness (NUMIF) has a current Accounts Payable & Accrued Expense of $2.31 Mil. The current Accounts Payable & Accrued Expense is $2.31 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable & Accrued Expense calculated?
Accounts Payable & Accrued Expense is calculated from a company's financial statements. For Numinus Wellness (NUMIF), the current Accounts Payable & Accrued Expense is $2.31 Mil as of May. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Numinus Wellness Business Description

Address 801 - 33 Water Street, Vancouver, BC, CAN, V6B 1R4
Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.